Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

2608

LikeLikedUnlike

Episodes 646-660 of 745

What Are the Emerging Therapies for Managing Gout?
MinuteCE®
What Are the Emerging Therapies for Managing Gout?
- Richard Johnson, MD
  Peer
- John K. Botson, MD, RPh
  Peer
Should We Look for Gout in the Cardiology Clinic?
MinuteCE®
Should We Look for Gout in the Cardiology Clinic?
- Richard Johnson, MD
  Peer
- Brittany Weber, MD, PhD
  Peer
Fertility and Safety of IBD Medications During Pregnancy – IBD Pro Webinar Series
Crohn’s & Colitis Foundation Perspectives
Fertility and Safety of IBD Medications During Pregnancy – IBD Pro Webinar Series
- Marla C Dubinsky, MD
  Peer
- Rishika Chugh, MD
  Peer
Mitigating Risk in New IBD Treatments– IBD Pro Webinar Series
CME/CE
Mitigating Risk in New IBD Treatments– IBD Pro Webinar Series
- Parakkal Deepak, MBBS, MS
  Peer
- Preetika Sinh, MD
  Peer
Achieving Success in IgAN & FSGS
CME/CE
Achieving Success in IgAN & FSGS
- Siân Griffin, MD, PhD
  Peer
- Jürgen Floege, MD
  Peer
- Loreto Gesualdo, MD, FERA
  Peer
Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
CME/CE
Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
- David Staskin, MD
  Peer
- Roger Dmochowski, MD
  Peer
advertisement
New Treatments in IBD – Professional Webinar Series
CME/CE
New Treatments in IBD – Professional Webinar Series
- Miguel Regueiro, MD
  Peer
- Katie Falloon, MD
  Peer
- Shubha Bhat, PharmD
  Peer
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
CME/CE
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
- Nirav Y. Raval, MD, FACC
  Peer
- Gurusher Panjrath, MD, FACC, FAHA, FHFSA
  Peer
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CE
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
- Thilo Krüger, MD, PhD
  Peer
- Steven Fishbane, MD
  Peer
- Lucio Manenti, MD, PhD
  Peer
Can We Do Better in IgAN?
CME/CE
Can We Do Better in IgAN?
- Jonathan Barratt, PhD
  Peer
- Annette Bruchfeld, MD, PhD
  Peer
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CE
KALMing the Itch: Improving QoL in Patients with CKD-aP
- Joel Topf, MD
  Peer
- Kieran McCafferty, MD
  Peer
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CE
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
- Jonathan Barratt, PhD
  Peer
- Donald E. Kohan, MD, PhD
  Peer
advertisement
Separating Fact from Fiction: The Realities of CKD-aP
CME/CE
Separating Fact from Fiction: The Realities of CKD-aP
- Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
  Peer
- Antoine Lanot, MD, PhD
  Peer
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
CME/CE
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
- Javed Butler, MD
  Peer
- John P. Boehmer, MD
  Peer
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
CME/CE
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Roberto Romero, MD, DMedSci
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended